Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.
about
Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradicationStability of yellow fever virus under recombinatory pressure as compared with chikungunya virusOligonucleotide fingerprint analysis of enterovirus 70 isolates from the 1980 to 1981 pandemic of acute hemorrhagic conjunctivitis: evidence for a close genetic relationship among Asian and American strains.Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses.Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.Nonhomologous recombination between defective poliovirus and coxsackievirus genomes suggests a new model of genetic plasticity for picornavirusesComparative sensitivities of Sabin and Mahoney poliovirus type 1 prototype strains and two recent isolates to low concentrations of glutaraldehydePolio vaccine: is it time for a change?Mechanisms controlling virulence thresholds of mixed viral populations.Comparative sensitivity of the echovirus type 25 JV-4 prototype strain and two recent isolates to glutaraldehyde at low concentrationsComparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1bAn Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses.A Sabin 1 poliovirus-based vaccine vector transfects Vero cells with high efficiencyIdentification of vaccine-related polioviruses by hybridization with specific RNA probesQuantitation of relative fitness and great adaptability of clonal populations of RNA virusesDetermination of the poliovirus RNA polymerase error frequency at eight sites in the viral genome.RNA virus quasispecies populations can suppress vastly superior mutant progeny.WHO collaborative study on the use of monoclonal antibodies for the intratypic differentiation of poliovirus strains.Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus.Extreme heterogeneity in populations of vesicular stomatitis virusNucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccineDirect method for quantitation of extreme polymerase error frequencies at selected single base sites in viral RNA.Genetic analysis of the attenuation phenotype of poliovirus type 1.A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.Site-directed mutagenesis of proteinase 3C results in a poliovirus deficient in synthesis of viral RNA polymerase.Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains.Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies.Characterization of genetic changes occurring in attenuated poliovirus 2 during persistent infection in mouse central nervous systems.A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humansPoliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.Natural variation of poliovirus neutralization epitopes.Impact on routine diagnosis of echovirus infections of intratypic differentiation and antigenic variation in echovirus type 25 studied by using monoclonal antibodiesImmunization issues in pediatric travelers.Heterogeneity of capsid proteins of echovirus type 25 wild-type strain and prototype strain, studied by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting.Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus.Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).Phenotypic and genomic analysis of serotype 3 Sabin poliovirus vaccine produced in MRC-5 cell substrate.A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating.Recombinant polioviruses as candidates for oral live poliovaccines.
P2860
Q24683132-FCCAE4AF-635C-4078-9EA4-04801436CE32Q28741831-B2B52EDA-1998-493E-8913-FE5EDB66ABD8Q30412373-609CBDCF-20C2-44ED-B279-C552BF4360BAQ33346729-08C324EE-44B4-48DB-B315-1EFCA17F5262Q33438422-B53A9EA0-541F-48E0-BC42-25F87FBD3211Q33809550-36E6D441-1B61-410D-A396-9CB8DB4C8B85Q34026234-FFBD7244-18F0-4A7F-950C-F64B9AE4B2F5Q35204065-C1FB6C8B-D295-4867-9D93-924D658ACF93Q35259765-6B5D452E-51C5-475C-8FFB-AB2830F29EDCQ35382314-E964F045-2023-415D-9A88-B56EE5C04FD0Q36051232-395A0EDF-F206-4262-90FC-12BDFC599091Q36252186-494C6FF4-B7D6-407E-9F5C-177923658088Q36316673-967CDAE3-4F72-492C-BB34-C1936D89D405Q36495639-5B5D4685-4C2B-4715-8156-F09C7CBFA372Q36519274-ED8233D4-CFD3-4E72-AD34-1AA6011E88E9Q36693778-4B8CA807-E374-4950-B8C2-E8938C9395B6Q36698278-DCCE54F4-7225-4E1E-97EC-FE0E554E25E8Q36796348-537E6F4C-7E97-4A34-84BA-01E3694EE3D9Q36799149-DD3EDCBB-5105-4C90-BEA8-E7272F2D3495Q36800731-76046BE1-8AE5-4282-B913-1164D0EB84D1Q36827358-26EFD75D-6590-45C0-8525-3100C441A02EQ36831862-105338C2-FC5E-411D-A2DC-534746054B6BQ36856043-480693D5-4837-4B5A-A221-A7857B67B349Q36862121-A3F69450-FA5A-4BD9-BBC5-FA9999E5C218Q36878746-E9B7AE72-D89F-4FF4-AF2A-C84BA78E811FQ36889778-2611927D-3845-49A8-8C34-C1FE45D91D7CQ36895904-1E7FE674-E00F-49C8-BDC5-959B37BB2092Q36905883-10B43FBA-6781-463A-AFAC-E20E878F2781Q36914220-691F0DF5-5E67-441B-87D9-16183D74B081Q36918813-56B84EB1-A4B6-4721-BC9F-6334196F006DQ36924249-DC5E7BCB-9B55-4CDE-948D-6B64D002D5DAQ37105978-72B732B6-5045-403C-BF4F-8DBCADD259AFQ37191042-159236E6-F33E-4165-8FDD-73F627B756B2Q37194794-371E71FC-EADD-4CED-A2A0-3D1D8D883200Q37241928-EC253346-AEEE-450F-B33C-E28D53CB0EB4Q37800652-49C9F474-D011-4CD8-8B0A-182470F4C25CQ38087428-E336E45A-6EA2-4223-9725-F0F55B832E6AQ39574954-F13E455F-25C5-4330-9BCF-9942452DC0A1Q40065544-B858492D-1385-4970-9FAF-D7EA5D2C6440Q40855711-0F27DEFE-EBEF-443B-881D-9C110C6E3608
P2860
Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.
@en
type
label
Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.
@en
prefLabel
Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.
@en
P2093
P1476
Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.
@en
P2093
P304
P356
10.1099/0022-1317-56-2-337
P407
P577
1981-10-01T00:00:00Z